CH Biotech R&D Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 459.31 million compared to TWD 696.67 million a year ago. Net income was TWD 190.01 million compared to TWD 334.1 million a year ago. Basic earnings per share from continuing operations was TWD 1.96 compared to TWD 3.44 a year ago. Diluted earnings per share from continuing operations was TWD 1.92 compared to TWD 3.39 a year ago.
For the six months, sales was TWD 1,260.16 million compared to TWD 1,287.71 million a year ago. Net income was TWD 582.86 million compared to TWD 603.44 million a year ago. Basic earnings per share from continuing operations was TWD 6 compared to TWD 6.22 a year ago. Diluted earnings per share from continuing operations was TWD 5.88 compared to TWD 6.11 a year ago.